Skip to main content
Clinical Trials/NCT06586151
NCT06586151
Recruiting
Not Applicable

Harnessing the Power of Technology to Develop a Population-based HIV Prevention Program for Trans Girls

Center for Innovative Public Health Research1 site in 1 country200 target enrollmentSeptember 1, 2024
ConditionsHIV Prevention

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV Prevention
Sponsor
Center for Innovative Public Health Research
Enrollment
200
Locations
1
Primary Endpoint
Number testing for HIV and/or sexual transmitted infections
Status
Recruiting
Last Updated
4 months ago

Overview

Brief Summary

If, over time, data suggest the intervention impacts HIV preventive behavior at the population level, it will be unique in that it can be quickly and cost effectively scaled up to impact thousands of trans girls and nonbinary youth assigned male at birth.

Registry
clinicaltrials.gov
Start Date
September 1, 2024
End Date
June 30, 2026
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Center for Innovative Public Health Research
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Youth will: (a) have been assigned male sex at birth and currently have a non-cisgender identity (e.g., transgender girl, non-binary, gender fluid, unsure); (b) be aged 14-18 years and have not yet graduated high school; (c) be English-speaking; (d) be the sole user of a cell phone with an unlimited text messaging plan; (e) have access to the Internet to complete online surveys; (f) intend to have the same cell number for the next 6 months; (g) provide informed assent; (h) not have taken part in a previous #TranscendentHealth study activity or know someone who is in the study to increase the diversity of input from transgirls, and (i) agree to enroll over the phone with study staff.

Exclusion Criteria

  • None beyond not meeting inclusion criteria

Outcomes

Primary Outcomes

Number testing for HIV and/or sexual transmitted infections

Time Frame: At any time after baseline through 8-months.

Self report of having been tested for either HIV or a sexually transmitted infection

Secondary Outcomes

  • Number Taking PreExposure Prophylaxis (PrEP) for HIV(At any time after baseline through 8-months.)

Study Sites (1)

Loading locations...

Similar Trials